- Home
- ARIS vs CVAC Comparison
ARIS vs CVAC Comparison
Compare ARIS & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARIS
- CVAC
- Stock Information
- Founded
- ARIS 2015
- CVAC 2000
- Country
- ARIS United States
- CVAC Germany
- Employees
- ARIS N/A
- CVAC N/A
- Industry
- ARIS Water Supply
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- ARIS Utilities
- CVAC Health Care
- Exchange
- ARIS Nasdaq
- CVAC Nasdaq
- Market Cap
- ARIS 828.1M
- CVAC 818.8M
- IPO Year
- ARIS 2021
- CVAC 2020
- Fundamental
- Price
- ARIS $25.91
- CVAC $3.12
- Analyst Decision
- ARIS Buy
- CVAC Buy
- Analyst Count
- ARIS 6
- CVAC 2
- Target Price
- ARIS $27.17
- CVAC $10.00
- AVG Volume (30 Days)
- ARIS 918.8K
- CVAC 717.4K
- Earning Date
- ARIS 05-06-2025
- CVAC 04-10-2025
- Dividend Yield
- ARIS 2.16%
- CVAC N/A
- EPS Growth
- ARIS 36.59
- CVAC N/A
- EPS
- ARIS 0.81
- CVAC 0.75
- Revenue
- ARIS $435,444,000.00
- CVAC $554,073,921.00
- Revenue This Year
- ARIS $12.52
- CVAC N/A
- Revenue Next Year
- ARIS $7.90
- CVAC $66.34
- P/E Ratio
- ARIS $32.11
- CVAC $4.21
- Revenue Growth
- ARIS 11.05
- CVAC 895.54
- 52 Week Low
- ARIS $13.24
- CVAC $2.22
- 52 Week High
- ARIS $33.95
- CVAC $5.28
- Technical
- Relative Strength Index (RSI)
- ARIS 43.28
- CVAC 53.48
- Support Level
- ARIS $24.28
- CVAC $3.05
- Resistance Level
- ARIS $25.48
- CVAC $3.02
- Average True Range (ATR)
- ARIS 2.25
- CVAC 0.19
- MACD
- ARIS -0.45
- CVAC 0.06
- Stochastic Oscillator
- ARIS 26.51
- CVAC 79.14
About ARIS Aris Water Solutions Inc.
Aris Water Solutions Inc is an environmental infrastructure and solutions company that helps customers reduce their water and carbon footprints. It has two primary revenue streams. The Produced Water Handling business gathers, transports, and, unless recycled, handles produced water generated from oil and natural gas production. The Water Solutions business develops and operates recycling facilities to treat, store and recycle produced water.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.